Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bioenvision Inc.

Division of Sanofi
www.bioenvision.com

Latest From Sandoz Canada

Medical Device Deals Update, September 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced in late July-September 2014.

Medical Device Deals

FDA Recall Powers Should Be Limited, FDA Says

Agency argues it can’t recall generic versions of Precedex as part of Hospira’s patent suit.

BioPharmaceutical Regulation

Savoring Sabex: Sandoz' Play in Injectable Generics

Sandoz, the generics unit of Novartis, is buying Sabex, a Canadian maker of injectable generics for $565 million cash, marking its entree into an attractive sector of generics and also the Canadian generics market. The 6X sales multiple aimed to dissuade Sabex owners from shopping for another buyer. Novartis is the only big pharma company to succeed in generics. Its play is opportunistic, but a secondary effect is a free-market response to pressure on big pharma to make drugs more affordable.
BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Sanofi
  • Senior Management
  • Christopher B Wood, MD, Pres. & CEO
    James S Scibetta, CFO
    MaryJane Rafii, VP, Reg. Affairs
  • Contact Info
  • Bioenvision Inc.
    Phone: (212) 750-6700
    509 Madison Ave., Ste. 404
    New York, NY 10022
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register